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Abstract 
Genome-wide association studies (GWAS) have 
discovered hundreds of genetic loci for resting heart rate 
(RHR). However, the impact of intra-individual variation 
in RHR on GWAS results is unclear. We evaluated this 
impact by analyzing two RHR recordings from N ~61,000 
subjects from UK Biobank. In addition, we modelled 
variations in RHR as independent white zero-mean 
Gaussian noise with a standard deviation of 0.5x, 1x, and 
2x the standard deviation of the difference between the 
original RHR values (4, 8, and 16 bpm, respectively). The 
two original RHR recordings were highly correlated 
(ρ=0.77), but results from the genetic analyses were 
slightly different: the number of genome-wide significant 
(p < 5x10-8) variants at the locus with the strongest 
reported association (MYH6): n=39 vs. n=34; the p-
value of the corresponding lead-variant, 3.6x10-24 vs. 
2.1x10-19; and the estimated heritability 20.0% vs. 16.7%. 
Simulated data showed an inverse relationship between 
RHR variation and genetic association strength and 
heritability. Results formally demonstrate the impact of 
intra-individual RHR variability on the discovery of 




Elevated resting heart rate (RHR) is a heritable marker 
of cardiovascular mortality with an estimated heritability 
between 50-70% in twin studies[1, 2]. Consequently, 
several genome-wide association studies (GWAS) have 
been undertaken to elucidate potential mechanisms 
underlying the genetic regulation of RHR[3-5].  
Importantly, the reliability and interpretation of 
GWAS results relies on the reproducibility of the 
phenotypic data. From this perspective,  heart rate is not 
constant but varies as a result of physiological (autonomic 
and hormonal control) and environmental factors (time of 
day, mental stress, etc)[6]. As a result, RHR 
measurements taken from the same individuals can differ 
significantly depending on when, where and how the 
measurements were taken. Studies investigating the 
genetic associations of blood pressure have estimated a 
20% gain in statistical power with long-term average 
measurements as compared to single-measurement 
associations. However, it is unclear how the level of 
variation in RHR affects the discovery of genetic 
variants. Increased may introduce false-negative GWAS 
results by increasing the p-values of associations to values 
above significance threshold. Alternatively, it is also 
possible that increased variation may promote 
overestimation of certain associations leading to false-
positive results (e.g. spurious associations). Replication of 
genetic association results in an independent cohort is 
important to lessen the likelihood of false positives. 
However, if replication data is based on data with 
increased variation in intra-individual RHR, it may impair 
replication of genetic associations.  
The objective of this work was to evaluate the effect of 
variability in  RHR measurements on genetic association 
results by conducting a physiological and a simulation 
study based on a large dataset of two repeated recordings 




Two automated recordings of RHR were obtained 
from N=74,725 participants from the UK Biobank study. 
RHR was both recorded during a blood pressure 
assessment (referred to as RHR recording 1), and during 
the pre-exercise resting phase of an ECG exercise stress 
test (referred to as RHR recording 2). We applied genetic 
quality control to exclude individuals with poor genotype 
quality including high heterozygosity / missingness and 
sex discordance, as supplied by UK Biobank (N=3126) 
and restricted our analysis to individuals with European 
ancestry (N=65,042). In line with previous studies on  
RHR, we further excluded individuals  with existing 
cardiovascular conditions known to affect RHR 
(including atrial fibrillation, history of myocardial 
infarction or heart failure, (supra)-ventricular tachycardia) 
as well as individuals on RHR altering medications (non-
dihydropyridine calcium antagonists). Individuals with 
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extreme RHR measurements (<40 or >120 bpm) were 
also excluded. The remaining 60,913 individuals were 
selected for analysis.  
Simulation study 
In addition to physiological variability observed by 
comparing the two RHR recordings, we also simulated 
physiological variability at different levels by creating 
additive zero-mean Gaussian noise models with standard 
deviation 0.5x, 1x, and 2x σHR (4 ,8, and 16bpm, 
respectively), where σHR represents the standard 
deviation of the difference between the two original RHR 
measurements. These values were added in a random 
order to the first of the two original RHR recordings, as 
the corresponding heritability was higher compared to the 
second recording.  The simulation was repeated 10 times 
for each variability level. 
Genetic studies 
We performed a genetic association study of 
chromosome 14, which harbours the locus with the 
strongest reported association for RHR (MYH6)[3]. Each 
RHR trait (two original traits and 30 simulated traits) 
were analysed using linear mixed model method (BOLT-
LMM)[8] under the additive genetic model including 
~328,000 imputed single nucleotide variants (SNVs) with 
minor allele frequency  ≥  1% and imputed quality > 0.3. 
The model included sex, age, and age2 as covariates, in 
line with previous studies[3]. Three methods were then 
used to compare the genetic results between traits and we 
used the results from the first original RHR recording as 
reference value:  
 
1) Counting the number of genome-wide 
significant (P < 5x10-8) variants at MYH6, and 
measuring the P-value of the lead variant (rs365990, 
discovered in RHR recording 1).  
2) Counting the number of genome-wide 
significant loci and the overlap with loci discovered for 
RHR recording 1. 
3) Comparing the estimated heritability.  
Individual loci were defined based on genomic 
distance of >500 Kb to each side of the lead variants. The 
heritability was estimated using BOLT-REML[8] with the 




The correlation between the two original RHR 
measurements was 0.77. From both recordings, the 
strongest genetic associations were obtained from the first 
recording: lead variant rs365990, P-value 3.6 x 10-24, 
compared to rs422068 with P-value 2.1 x 10-19 for the 
second recording. Both variants were located within only 
3kb of each other. The number of genome-wide 
significant SNVs at MYH6 was also higher for the first 
recording: N=39 compared to N=34 (all included in the 
N=39) for RHR recording 2. Finally, the estimated 
heritability was higher for recording 1 compared to 
recording 2: 20.0% versus 16.9%, respectively. 
Simulation study 
The correlation between original and simulated data 
reduced with increasing levels of RHR variation, 
correlation coefficient (cc)=0.93, 0.81, and 0.56 for 0.5, 
1, and 2x σHR (Fig. 1), respectively. The median 
correlation coefficient for variation level 1x σHR (8 bpm) 
was similar to the correlation between both original RHR 
recordings (0.77 vs. 0.81, respectively). The number of 
genome-wide significant SNVs at MYH6 decreased with 
increasing levels of variation with median values of: 
N=34 (interquartile range (IQR): 32-35), 28 (IQR: 26-33), 
and 1 (IQR: 0-5) for 0.5x, 1x, and 2x σHR respectively, 
versus N=39 in the original data (Fig. 2A). A similar 
trend was observed for the change in p-value of the lead 
variant at this locus: median –log10(P-value): 21.3 (IQR: 
20.7-21.7), 15.4 (IQR: 14.6-17.1), and 6.9 (IQR: 6.6-7.9), 
respectively compared to 23.4 for the original data and 
7.3 (p=5x10-8) for the generally accepted genome-wide 
significant threshold (Fig. 2B). The total number of 
discovered loci also decreased with increasing levels of 
variation in RHR: median number of discovered loci: 
N=3 (IQR: 3-3), 2 (IQR: 2-3), and 1 (IQR: 0-1) for 0.5x, 
1x, and 2x σHR respectively. All loci discovered in the 
simulated data overlapped with the loci identified in the 
original data, and therefore no non-overlapping loci were 
detected. Finally, heritability estimates decreased with 
increasing levels of variation in RHR (Fig 2C): 17.4% 
(IQR: 17.4%-17.5%), 12.8% (IQR: 12.5%-13.1%), and 
Fig. 1: Correlation between original and simulated RHR 
measurements. Black circles and error bars show the median 
correlation coefficient and interquartile range for each 
simulated level of variation. For comparison, the red triangle 
shows the variation and correlation measured between the two 
original recordings.  
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5.7% (IQR: 5.4%-6.3%) for 0.5x, 1x, and 2x σHR, 
respectively, compared to 20.0% for the original data. 
Fig. 2D, 2E, and 2F show a direct relationship between 
genetic association and heritability results when plotted as 
function of the phenotypic correlation.   
 
4. Discussion 
This work formally demonstrates the impact of 
physiological variability in RHR on the discovery of 
associated genetic variants. The main finding is that 
increased variation in RHR attenuates the strength of 
genetic associations and heritability estimates, but we did 
not observe evidence for spurious associations (e.g. false-
positive associations).  
Variability in RHR was observed between the two 
original RHR recordings. The fact that he second 
recording was taken just before an exercise stress test 
may have increased the variability as subjects may have 
experienced an anticipatory stress response to the actual 
stress test RHR[9]. We observed that the genetic 
associations were attenuated in the second recording 
demonstrating a potential effect of increased RHR 
variability. This finding supports previous studies that 
have shown that averaging blood pressure measurements 
increased statistical power to detect genetic associations 
compared to a single-measurement GWAS[10]. 
The results from the physiological study were 
compatible with the results from the simulation study. 
The simulation study highlights important implications on 
GWAS results. For example, even for 8 bpm of variation, 
on average only 2 out the 3 loci were discovered and the 
estimated heritability dropped from 20% to approximately 
15%. Although our results are based on the analysis of a 
single chromosome, our results suggest a potential loss of 
discoverable loci over the whole genome because of 
(increased) physiological variation in heart rate.   
This work is a first explorative study on the effect of 
RHR variation on GWAS results and has some 
limitations. RHR variations were modelled as 
independent white Gaussian noise, whereas, 
physiologically, the magnitude of the variation may 
depend on the RHR itself. For example, Fig. 2 shows that 
simulation data slightly overestimates the decrease in 
genetic association strength compared to the original data. 
Furthermore, we did not observe evidence of spurious 
associations, but the number of simulations was limited 
and we only investigated a section of the genome 
(chromosome 14). Future studies may increase the 
number of genetic variants to further evaluate false-
Fig. 2: Effect of simulated and real physiological variation in RHR on GWAS results and heritability estimates. (A) number of 
genome-wide significant (GWS) SNVs at MYH6 locus, (B) –log10 of the P-value of the lead variant and genome-wide significance 
threshold (p=5x10-8, red horizontal line) , and (C) estimated heritability, all plotted as function of the simulated variation level and with 
respect to the original results. Bottom row shows same parameters but plotted against phenotypic correlation between the simulated and 
original RHR data. Black circles represent median values from the simulation results and corresponding interquartile ranges are given 
by error bars. For comparison, red triangles present the results from comparing the two original RHR recordings.  
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positive associations. However, given the consistency of 
increasing P-values and decreasing heritability measures, 
we suspect false-positive results are unlikely to occur. 
In summary, this work highlights the important 
implications of physiological variability of RHR on the 
genetic association results. The importance of averaging 
measurements to improve accuracy is well established, 
but our results provide a more detailed overview of the 
impact of different levels of variation on genetic results 
for a single-measurement RHR GWAS. Whilst results 
focus on RHR, they may have broader implications, as 
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